DanielWIsenbargerMD
Cardiology • Cornelius, ORAdult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Hillsboro Cardiology, PC
Dr. Isenbarger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 SE 7th Ave
Ste 5400
Cornelius, OR 97123Phone+1 503-648-0731Fax+1 503-640-2747
Education & Training
Johns Hopkins UniversityFellowship, Interventional Cardiology, 2004 - 2005
National Capital ConsortiumFellowship, Cardiovascular Disease, 2001 - 2004- National Capital ConsortiumResidency, Internal Medicine, 1991 - 1994
Georgetown University School of MedicineClass of 1991
Certifications & Licensure
WA State Medical License 2021 - 2026
OR State Medical License 2007 - 2025
VA State Medical License 1993 - 2024
MD State Medical License 2003 - 2018
DC State Medical License 1993 - 1998- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FSCAI) Society of Cardiovascular Angiography and Interventions, 2006
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 115 citationsComparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999.Daniel W. Isenbarger, Charles W. Hoge, Apichai Srijan, Chittima Pitarangsi, Niyada Vithayasai
Emerging Infectious Diseases. 2002-02-01 - 29 citationsDetection of PCR products of the ipaH gene from Shigella and enteroinvasive Escherichia coli by enzyme linked immunosorbent assay.Orntipa Sethabutr, Malabi M. Venkatesan, Sylvia Yam, Lorrin W. Pang, Bonnie L. Smoak
Diagnostic Microbiology and Infectious Disease. 2000-05-01 - 48 citationsSafety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children i...Kazi Mizanur Rahman, Shams El Arifeen, K. Zaman, Mahbubur Rahman, Rubhana Raqib
Vaccine. 2011-02-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
